ATE493430T1 - Pantropisches hundecoronavirus - Google Patents

Pantropisches hundecoronavirus

Info

Publication number
ATE493430T1
ATE493430T1 AT05023371T AT05023371T ATE493430T1 AT E493430 T1 ATE493430 T1 AT E493430T1 AT 05023371 T AT05023371 T AT 05023371T AT 05023371 T AT05023371 T AT 05023371T AT E493430 T1 ATE493430 T1 AT E493430T1
Authority
AT
Austria
Prior art keywords
canine
pantropic
ecoronavirus
prophylaxis
dogs
Prior art date
Application number
AT05023371T
Other languages
English (en)
Inventor
Canio Buonavoglia
Nicola Decaro
Vito Martella
Gabriella Elia
Marco Campolo
Costantina Desario
Maria Tempesta
Original Assignee
Canio Buonavoglia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canio Buonavoglia filed Critical Canio Buonavoglia
Application granted granted Critical
Publication of ATE493430T1 publication Critical patent/ATE493430T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10RNA viruses
    • C07K16/102Coronaviridae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/165Coronaviridae, e.g. avian infectious bronchitis virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT05023371T 2005-10-26 2005-10-26 Pantropisches hundecoronavirus ATE493430T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05023371A EP1780216B1 (de) 2005-10-26 2005-10-26 Pantropisches Hundecoronavirus

Publications (1)

Publication Number Publication Date
ATE493430T1 true ATE493430T1 (de) 2011-01-15

Family

ID=36046489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05023371T ATE493430T1 (de) 2005-10-26 2005-10-26 Pantropisches hundecoronavirus

Country Status (5)

Country Link
EP (2) EP2283859A3 (de)
AT (1) ATE493430T1 (de)
DE (1) DE602005025649D1 (de)
ES (1) ES2355702T3 (de)
PT (1) PT1780216E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20111182A1 (it) * 2011-06-28 2012-12-29 Canio Buonavoglia Vaccino per coronavirus canino
CN103911462B (zh) * 2014-04-03 2015-06-10 河北国际旅行卫生保健中心 黄热、乙型脑炎、基孔肯雅、西尼罗的鉴别检测方法及引物和探针
CN107831317A (zh) * 2017-11-01 2018-03-23 杭州微瑞科技有限公司 犬冠状病毒抗体快速定量检测卡及使用方法
CN116375854A (zh) * 2023-04-18 2023-07-04 领地动物诊疗科技(厦门)有限公司 抗犬冠状病毒n蛋白抗体对及其制备方法、核酸分子、细胞株和应用
CN119331833B (zh) * 2024-09-28 2025-10-03 华中农业大学 一株犬冠状病毒弱毒株CCoV AS22及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine
EP0510773B1 (de) * 1991-04-25 2003-12-17 Akzo Nobel N.V. Subeinheits-Impfstoff gegen Hundecoronavirus
GB0217434D0 (en) * 2002-07-27 2002-09-04 Royal Vetinary College Biological material

Also Published As

Publication number Publication date
EP1780216A1 (de) 2007-05-02
EP2283859A2 (de) 2011-02-16
ES2355702T3 (es) 2011-03-30
DE602005025649D1 (de) 2011-02-10
PT1780216E (pt) 2011-02-03
EP1780216B1 (de) 2010-12-29
EP2283859A3 (de) 2011-05-04

Similar Documents

Publication Publication Date Title
NL301089I2 (nl) imlifidase
HUS1800019I1 (hu) Acilezett GLP-1 vegyületek
CR20110206A (es) Método de uso de una sepa de bacillus subtilis para mejorar la salud de animales
EP2087772A4 (de) Lichtquelle mit lichtemittierenden clustern
NO20063624L (no) FC region varianter
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
PT2987796T (pt) Boronoftalidas substituídas por halogéneo para o tratamento de infecções
BRPI0717753A2 (pt) Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição.
NI200500139S (es) Mordedor para perro caso 29/223,860
EA201100297A1 (ru) Биотесты на белок polyq
CR10165A (es) "uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento de depresión"
NL2000373A1 (nl) Antibacteriele middelen.
CR11473A (es) Uso de 3,11 b-cis-dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
DK1765318T3 (da) Middelkæde fedtsyrer anvendelige som antimikrobielle midler
AR057643A1 (es) Lacosamida para terapia adjunta
DE602006001073D1 (de) Viehmarke
ATE493430T1 (de) Pantropisches hundecoronavirus
BR0312211A (pt) difluortioacetamidas de oxazolidinonas como agentes antibacterianos
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
GT200500308A (es) Nonadepsipeptidos acilados ii
UY30769A1 (es) Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas
EP1793984A4 (de) Entsafter mit antriebs- und rückführnocken für entsafterschalenbewegung
AR055072A1 (es) Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical
ITTV20050186A1 (it) Lettino per l'abbronzatura del corpo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties